Specifically, BRD9 bromodomain inhibitors hinder the proliferation of cancer cells while inducing apoptosis in acute myeloid leukaemia,4, 7 rhabdoid tumour8 and triple‐negative breast cancer.9 This evidence concerns the gene BRD9 and cancer.